For some reason Samsung felt good enough about CYDY's prospects to allow them to get this far behind. I imagine they have been kept in the loop & will cooperate as much as prescribed & then some to get paid vs pushing CYDY under. I would think that a company like Samsung would be aware of the challenges & finances of an OTC biotech. IMO, they knew what they were getting into & chose to do so anyway. I do not see them jumping ship now. They are probably thinking what we are: "We will be richly rewarded for our patience."